The Medicare Evidence Development and Coverage Advisory Committee expressed moderate confidence Wednesday in treatments of peripheral artery disease. The lukewarm vote means it’s unlikely Medicare will pay for tests to diagnose or treat this disease… …read more
Source:: Healtchare
